0

Critical Care Drugs Market Insights, Trends, Opportunity & Forecast

Critical Care Drugs Market By Dosage Class (Opioids (Morphine, Pethidine, Naloxone, Fentanyl), Benzodiazepines (Diazepam, Midazolam, Lorazepum, Flumazenil), Sedatives, Anesthetics and Others), By Therapeutic Conditions (Cardiovascular, Oncology, CNS, Pain Management, Respiratory, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Global Market Size, Development, Growth and Demand Forecast, 2014-2024

Category: Pharmaceutical | Report ID: FAMR-0096 | Published on: Nov 2019 | Share:         

Select License Type
  • Single User License $3825 USD
  • Multi-User License $4608 USD
  • Corporate User License $5346 USD
  • Report Description
  • Table Of Content
  • Request Methodology

Overview

Critical Care drugs are used to treat significant injuries and illnesses during an emergency, including surgeries. They are used in specific care units such as coronary care unit (CCU), intensive care unit (ICU), or any other particular healthcare or trauma center. Opioids, Benzodiazepines, and sedatives are some drugs used in intensive care units (ICU), and Adrenaline, Atropine, Xylocard, Calcium gluconate, Soda bicarbonate are used as life-saving drugs. Critical care 5120

An increase in the prevalence of critical care health problems is expected to propel the essential drugs of care market growth.

Increase in prevalence of critical care health problem like accidents, surgery, infections, and severe breathing problems which may occur due to the many factors like accidental cases, age factors, sudden heart attack, etc. is expected to boost the revenue of critical care drugs market. For instance, According to the World Health Organization (WHO), approximately 1.35 million people die each year as a result of road traffic crashes, and 93% of the world's fatalities on the roads occur in low- and middle-income countries.

However, a shortage of various critical care drugs lead to high price and in turn, posing a challenge for patients, seeking treatment. Thus, manufacturers are emphasizing strategic partnerships with other pharmaceutical companies to address drug shortages. For instance, in May 2019, ProvideGx, LLC, a consolidated subsidiary of Premier Inc., entered into a partnership agreement with Fresenius Kabi to help mitigate national shortages of injectable thiamine, hydromorphone, lidocaine, morphine sulfate, and diphenhydramine. The supply of these products by Fresenius Kabi and ProvideGx, LLC, will be available for purchase by any health system or healthcare provider at competitive prices. Thus, such an initiative will drive the growth of critical care drugs to be used in hospitals and clinics to treat patients with critical and chronic conditions at a faster pace.

Critical Care Drugs Market Regional Analysis 

Based on the region, North America is expected to show the leading position in the critical care drugs market. This is owing to a rise in the geriatric population who are more vulnerable to chronic diseases and improved healthcare infrastructure. According to the Society of Critical Care Medicine (SCCM), more than 5 million patients are admitted annually to U.S. ICUs for intensive or invasive monitoring, stabilization of acute or life-threatening medical problems, comprehensive management of injury or illness.

Further, According to the American Health Association (AHA) 2015 annual survey from 2010 to 2015, the U.S. acute care hospitals has increased by 10.3% from 4,862 to 2,977. Additionally, it has been observed that, in 4862, acute care registered hospitals, there were at least 10 acute care beds and at least 1 ICU bed. Thus, the increase in healthcare spending for critical care is expected to drive the demand for critical care drugs market during the forecast period.

The Asia Pacific also contributes remarkable growth in the critical care drugs market attributed to increase initiatives by pharmaceutical manufacturers to develop and process new drugs as per the quality norms set by respective country's authority and also focus on building secure logistics networks to continue the supply of drugs across regions. For instance, Kritikos Care is one of the top 10 pharmaceutical company in India and deliver a broad range of products (that covers up all major therapeutic areas and health problems) to many leading hospitals and medical center in India. Additionally, this company has a vast supply chain that is spread all over the country to reach out their products to every needy patient.

Moreover, in February 2018, Asahi Kasei Pharma introduced Kevzara 150 mg Syringe and 200 mg Syringe Subcutaneous Injection in Japan. Kevzara got approved for the treatment of rheumatoid arthritis in patients who have had an inadequate response to conventional therapies in Japan. Hence, a rise in approvals of life-saving drugs by the government in the Asia Pacific is expected to provide lucrative opportunities for the critical care drugs market during the forecast period.

Key players operating in the critical care drugs markets include Pfizer, Mallinckrodt, Lupin Limited, Actavis, Janssen Pharmaceuticals, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals, Purdue Pharma, Lannett Company, Inc., Lavipharm Labs, Mylan Technologies, DURECT Corporation, Aveva, Watson, Impax, ANI Pharmaceuticals, Inc., Ranbaxy and others.

Get a brochure of this research study Click Here

Critical Care Drugs Market-Taxonomy

By Dosage Class
-Opioids
--Morphine
--Pethidine
-- Naloxone
--Fentanyl
-Benzodiazepines
-- Diazepam
--Midazolam
-- Lorazepum
--Flumazenil
-Sedatives
-Anesthetics
-Others

By Therapeutic Conditions
-Cardiovascular
-Oncology
-CNS
-Pain Management
-Respiratory
-Others

By Dosage Form
- Hospital Pharmacies
- Retail Pharmacies
-Online Pharmacies

By Region
-North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Issues in Global Critical Care Drugs Market
2.1. North America
2.2. Europe
2.3. Asia Pacific
2.4. Europe
2.5. Middle East & Africa

3. Global Critical Care Drugs Market Trends
4. Opportunities in Global Critical Care Drugs Market
5. Recent Industry Activities, 2018
6. Porter's Five Forces Analysis
7. Macro-Economic Trends
8. PEST Analysis
9. Market Value Chain and Supply Chain Analysis
10. Global Critical Care Drugs Market Value (USD Million), 2018-2024

11. Global Critical Care Drugs Market Segmentation Analysis, By Dosage Class
11.1. Introduction
11.2. Market Attractiveness, By Dosage Class
11.3. BPS Analysis, By Dosage Class
11.4. Opioids Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.4.1. Morphine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.4.2. Pethidine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.4.3. Naloxone Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.4.4. Fentanyl Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.5. Benzodiazepines Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.5.1. Diazepam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.5.2. Midazolam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.5.3. Lorazepum Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.5.4. Flumazenil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.6. Sedatives Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.7. Anesthetics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.8. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

12. Global Critical Care Drugs Market Segmentation Analysis, By Therapeutic Conditions
12.1. Introduction
12.2. Market Attractiveness, By Therapeutic Conditions
12.3. BPS Analysis, By Therapeutic Conditions
12.4. Cardiovascular Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
12.5. Oncology Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
12.6. CNS Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
12.7. Pain Management Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
12.8. Respiratory Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
12.9. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

13. Global Critical Care Drugs Market Segmentation Analysis, By Distribution Channel
13.1. Introduction
13.2. Market Attractiveness, By Distribution Channel
13.3. BPS Analysis, By Distribution Channel
13.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
13.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
13.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14. Geographical Analysis
14.1. Introduction
14.2. North America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.2.1. By Dosage Class
14.2.1.1. Introduction
14.2.1.2. Market Attractiveness, By Dosage Class
14.2.1.3. BPS Analysis, By Dosage Class
14.2.1.4. Opioids Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.4.1. Morphine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.4.2. Pethidine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.4.3. Naloxone Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.4.4. Fentanyl Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.5. Benzodiazepines Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.5.1. Diazepam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.5.2. Midazolam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.5.3. Lorazepum Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.5.4. Flumazenil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.6. Sedatives Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.7. Anesthetics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.8. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.2.2. By Therapeutic Conditions
14.2.2.1. Introduction
14.2.2.2. Market Attractiveness, By Therapeutic Conditions
14.2.2.3. BPS Analysis, By Therapeutic Conditions
14.2.2.4. Cardiovascular Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.2.5. Oncology Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.2.6. CNS Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.2.7. Pain Management Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.2.8. Respiratory Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.2.9. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.2.3. By Distribution Channel
14.2.3.1. Introduction
14.2.3.2. Market Attractiveness, By Distribution Channel
14.2.3.3. BPS Analysis, By Distribution Channel
14.2.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.2.4. By Country
14.2.4.1. Market Attractiveness, By Country
14.2.4.2. BPS Analysis, By Country
14.2.4.3. U.S. Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.4.4. Canada Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3. Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.3.1. By Dosage Class
14.3.1.1. Introduction
14.3.1.2. Market Attractiveness, By Dosage Class
14.3.1.3. BPS Analysis, By Dosage Class
14.3.1.4. Opioids Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.4.1. Morphine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.4.2. Pethidine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.4.3. Naloxone Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.4.4. Fentanyl Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.5. Benzodiazepines Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.5.1. Diazepam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.5.2. Midazolam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.5.3. Lorazepum Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.5.4. Flumazenil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.6. Sedatives Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.7. Anesthetics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.8. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.3.2. By Therapeutic Conditions
14.3.2.1. Introduction
14.3.2.2. Market Attractiveness, By Therapeutic Conditions
14.3.2.3. BPS Analysis, By Therapeutic Conditions
14.3.2.4. Cardiovascular Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.2.5. Oncology Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.2.6. CNS Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.2.7. Pain Management Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.2.8. Respiratory Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.2.9. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.3.3. By Distribution Channel
14.3.3.1. Introduction
14.3.3.2. Market Attractiveness, By Distribution Channel
14.3.3.3. BPS Analysis, By Distribution Channel
14.3.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.3.4. By Country
14.3.4.1. Market Attractiveness, By Country
14.3.4.2. BPS Analysis, By Country
14.3.4.3. Germany Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.4. United Kingdom Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.5. France Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.6. Italy Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.7. Spain Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.8. Russia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.9. Rest of Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4. Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.4.1. By Dosage Class
14.4.1.1. Introduction
14.4.1.2. Market Attractiveness, By Dosage Class
14.4.1.3. BPS Analysis, By Dosage Class
14.4.1.4. Opioids Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.4.1. Morphine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.4.2. Pethidine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.4.3. Naloxone Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.4.4. Fentanyl Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.5. Benzodiazepines Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.5.1. Diazepam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.5.2. Midazolam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.5.3. Lorazepum Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.5.4. Flumazenil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.6. Sedatives Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.7. Anesthetics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.8. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.4.2. By Therapeutic Conditions
14.4.2.1. Introduction
14.4.2.2. Market Attractiveness, By Therapeutic Conditions
14.4.2.3. BPS Analysis, By Therapeutic Conditions
14.4.2.4. Cardiovascular Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.2.5. Oncology Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.2.6. CNS Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.2.7. Pain Management Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.2.8. Respiratory Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.2.9. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.4.3. By Distribution Channel
14.4.3.1. Introduction
14.4.3.2. Market Attractiveness, By Distribution Channel
14.4.3.3. BPS Analysis, By Distribution Channel
14.4.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.4.4. By Country
14.4.4.1. Market Attractiveness, By Country
14.4.4.2. BPS Analysis, By Country
14.4.4.3. China Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.4. India Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.5. Japan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.6. South Korea Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.7. Indonesia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.8. Taiwan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.9. Australia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.10. New Zealand Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.11. Rest of Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5. Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.5.1. By Dosage Class
14.5.1.1. Introduction
14.5.1.2. Market Attractiveness, By Dosage Class
14.5.1.3. BPS Analysis, By Dosage Class
14.5.1.4. Opioids Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.4.1. Morphine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.4.2. Pethidine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.4.3. Naloxone Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.4.4. Fentanyl Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.5. Benzodiazepines Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.5.1. Diazepam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.5.2. Midazolam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.5.3. Lorazepum Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.5.4. Flumazenil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.6. Sedatives Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.7. Anesthetics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.8. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.5.2. By Therapeutic Conditions
14.5.2.1. Introduction
14.5.2.2. Market Attractiveness, By Therapeutic Conditions
14.5.2.3. BPS Analysis, By Therapeutic Conditions
14.5.2.4. Cardiovascular Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.2.5. Oncology Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.2.6. CNS Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.2.7. Pain Management Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.2.8. Respiratory Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.2.9. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.5.3. By Distribution Channel
14.5.3.1. Introduction
14.5.3.2. Market Attractiveness, By Distribution Channel
14.5.3.3. BPS Analysis, By Distribution Channel
14.5.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.5.4. By Country
14.5.4.1. Market Attractiveness, By Country
14.5.4.2. BPS Analysis, By Country
14.5.4.3. Brazil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.4.4. Mexico Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.4.5. Rest of Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6. Middle East & Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.6.1. By Dosage Class
14.6.1.1. Introduction
14.6.1.2. Market Attractiveness, By Dosage Class
14.6.1.3. BPS Analysis, By Dosage Class
14.6.1.4. Opioids Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.4.1. Morphine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.4.2. Pethidine Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.4.3. Naloxone Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.4.4. Fentanyl Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.5. Benzodiazepines Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.5.1. Diazepam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.5.2. Midazolam Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.5.3. Lorazepum Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.5.4. Flumazenil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.6. Sedatives Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.7. Anesthetics Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.8. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.6.2. By Therapeutic Conditions
14.6.2.1. Introduction
14.6.2.2. Market Attractiveness, By Therapeutic Conditions
14.6.2.3. BPS Analysis, By Therapeutic Conditions
14.6.2.4. Cardiovascular Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.2.5. Oncology Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.2.6. CNS Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.2.7. Pain Management Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.2.8. Respiratory Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.2.9. Others Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.6.3. By Distribution Channel
14.6.3.1. Introduction
14.6.3.2. Market Attractiveness, By Distribution Channel
14.6.3.3. BPS Analysis, By Distribution Channel
14.6.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.6.4. By Geography
14.6.4.1. Market Attractiveness, By Geography
14.6.4.2. BPS Analysis, By Geography
14.6.4.3. GCC Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.4.4. North Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.4.5. South Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.4.6. Rest of Middle East & Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

15. Competitive Landscape
15.1. Market Share of Key Players
15.2. Market Positioning of Major Players in Global Critical Care Drugs Market
15.3. Company Profiles
15.3.1. Pfizer
15.3.1.1. Company Overview
15.3.1.2. Product Offered
15.3.1.3. Business Strategy
15.3.1.4. Financials
15.3.1.5. SWOT Analysis
15.3.1.6. Market Share Analysis
15.3.1.7. Key Achievements & Developments
15.3.2. Mallinckrodt
15.3.3. Lupin Limited
15.3.4. Actavis
15.3.5. Janssen Pharmaceuticals
15.3.6. Dr. Reddy's Laboratories
15.3.7. Teva Pharmaceutical Industries Ltd.
15.3.8. Endo Pharmaceuticals
15.3.9. Purdue Pharma
15.3.10. Lannett Company, Inc.
15.3.11. Lavipharm Labs
15.3.12. Mylan Technologies
15.3.13. DURECT Corporation
15.3.14. Aveva
15.3.15. Watson
15.3.16. Impax
15.3.17. ANI Pharmaceuticals, Inc.
15.3.18. Ranbaxy
15.3.19. Other Major & Niche Players

16. Disclaimer

Request For Customization



Request Customization

Check Discount



Request Discount
  • Sanofi
  • KOKUYO CO., LTD.
  • 3M Company
  • Danaher Corporation
  • Sekisui Chemical
  • The HC Companies
  • Office Depot
  • The Saudi Arabian Amiantit Company
  • Parade Technologies, Ltd.
  • FKB Válvulas e Comportas
  • Sunon
  • Sou Inc
  • McKinsey & Company
  • Deloitte
  • CQMS Razer
  • Dupont